128 related articles for article (PubMed ID: 11855677)
1. Protective effect of thiaton, an antispasmodic drug, against indomethacin-induced intestinal damage in rats.
Kunikata T; Miyazawa T; Kanatsu K; Kato S; Takeuchi K
Jpn J Pharmacol; 2002 Jan; 88(1):45-54. PubMed ID: 11855677
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats.
Takeuchi K; Miyazawa T; Tanaka A; Kato S; Kunikata T
Digestion; 2002; 66(1):30-41. PubMed ID: 12379813
[TBL] [Abstract][Full Text] [Related]
3. 16,16-Dimethyl prostaglandin E2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors.
Kunikata T; Tanaka A; Miyazawa T; Kato S; Takeuchi K
Dig Dis Sci; 2002 Apr; 47(4):894-904. PubMed ID: 11991626
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic effect of irsogladine maleate against indomethacin-induced small intestinal lesions in rats.
Kamei K; Kubo Y; Kato N; Hatazawa R; Amagase K; Takeuchi K
Dig Dis Sci; 2008 Oct; 53(10):2657-66. PubMed ID: 18306037
[TBL] [Abstract][Full Text] [Related]
5. Protection by constitutively formed nitric oxide of intestinal damage induced by indomethacin in rats.
Tanaka A; Mizoguchi H; Kunikata T; Miyazawa T; Takeuchi K
J Physiol Paris; 2001; 95(1-6):35-41. PubMed ID: 11595416
[TBL] [Abstract][Full Text] [Related]
6. Lack of small intestinal ulcerogenecity of nitric oxide-releasing indomethacin, NCX-530, in rats.
Mizoguchi H; Hase S; Tanaka A; Takeuchi K
Aliment Pharmacol Ther; 2001 Feb; 15(2):257-67. PubMed ID: 11148446
[TBL] [Abstract][Full Text] [Related]
7. Factors involved in upregulation of inducible nitric oxide synthase in rat small intestine following administration of nonsteroidal anti-inflammatory drugs.
Takeuchi K; Yokota A; Tanaka A; Takahira Y
Dig Dis Sci; 2006 Jul; 51(7):1250-9. PubMed ID: 16944022
[TBL] [Abstract][Full Text] [Related]
8. Intestinal protection by lafutidine, a histamine H(2)-receptor antagonist, against indomethacin-induced damage in rats--role of endogenous nitric oxide.
Tanaka A; Mizoguchi H; Hase S; Miyazawa T; Takeuchi K
Med Sci Monit; 2001; 7(5):869-77. PubMed ID: 11535926
[TBL] [Abstract][Full Text] [Related]
9. Sildenafil, an inhibitor of phosphodiesterase subtype 5, prevents indomethacin-induced small-intestinal ulceration in rats via a NO/cGMP-dependent mechanism.
Kato N; Mashita Y; Kato S; Mitsufuji S; Yoshikawa T; Takeuchi K
Dig Dis Sci; 2009 Nov; 54(11):2346-56. PubMed ID: 19101800
[TBL] [Abstract][Full Text] [Related]
10. Dopamine-induced protection against indomethacin-evoked intestinal lesions in rats--role of anti-intestinal motility mediated by D2 receptors.
Miyazawa T; Matsumoto M; Kato S; Takeuchi K
Med Sci Monit; 2003 Feb; 9(2):BR71-7. PubMed ID: 12601282
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of rebamipide on indomethacin-induced intestinal damage in rats.
Mizoguchi H; Ogawa Y; Kanatsu K; Tanaka A; Kato S; Takeuchi K
J Gastroenterol Hepatol; 2001 Oct; 16(10):1112-9. PubMed ID: 11686837
[TBL] [Abstract][Full Text] [Related]
12. Induction of small intestinal damage in rats following combined treatment with cyclooxygenase-2 and nitric-oxide synthase inhibitors.
Ohno R; Yokota A; Tanaka A; Takeuchi K
J Pharmacol Exp Ther; 2004 Aug; 310(2):821-7. PubMed ID: 15044560
[TBL] [Abstract][Full Text] [Related]
13. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K
J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
[TBL] [Abstract][Full Text] [Related]
14. Functional mechanism underlying cyclooxygenase-2 expression in rat small intestine following administration of indomethacin: relation to intestinal hypermotility.
Tanaka A; Matsumoto M; Hayashi Y; Takeuchi K
J Gastroenterol Hepatol; 2005 Jan; 20(1):38-45. PubMed ID: 15610444
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide, superoxide radicals and mast cells in pathogenesis of indomethacin-induced small intestinal lesions in rats.
Konaka A; Nishijima M; Tanaka A; Kunikata T; Kato S; Takeuchi K
J Physiol Pharmacol; 1999 Mar; 50(1):25-38. PubMed ID: 10210152
[TBL] [Abstract][Full Text] [Related]
16. Lubiprostone prevents nonsteroidal anti-inflammatory drug-induced small intestinal damage by suppressing the expression of inflammatory mediators via EP4 receptors.
Hayashi S; Kurata N; Yamaguchi A; Amagase K; Takeuchi K
J Pharmacol Exp Ther; 2014 Jun; 349(3):470-9. PubMed ID: 24713141
[TBL] [Abstract][Full Text] [Related]
17. Protection by aspirin of indomethacin-induced small intestinal damage in rats: mediation by salicylic acid.
Takeuchi K; Hase S; Mizoguchi H; Komoike Y; Tanaka A
J Physiol Paris; 2001; 95(1-6):51-7. PubMed ID: 11595418
[TBL] [Abstract][Full Text] [Related]
18. Urocortin prevents indomethacin-induced small intestinal lesions in rats through activation of CRF2 receptors.
Kubo Y; Kumano A; Kamei K; Amagase K; Abe N; Takeuchi K
Dig Dis Sci; 2010 Jun; 55(6):1570-80. PubMed ID: 19707872
[TBL] [Abstract][Full Text] [Related]
19. Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage.
Takeuchi K; Tanaka A; Kato S; Amagase K; Satoh H
Clin Chim Acta; 2010 Apr; 411(7-8):459-66. PubMed ID: 20074562
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of lafutidine against indomethacin-induced intestinal ulceration in rats: relation to capsaicin-sensitive sensory neurons.
Kato S; Tanaka A; Kunikata T; Umeda M; Takeuchi K
Digestion; 2000; 61(1):39-46. PubMed ID: 10671773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
